[New post] Greylock Partners Announces Unique $500 Million Venture to act as Seed Capital Funding for Earliest Stage Startups

sjwilliamspa posted: " Greylock Partners Announces Unique $500 Million Venture to act as Seed Capital Funding for Earliest Stage Startups Reporter: Stephen J. Williams, Ph.D. Greylock Partners CEO Reid Hoffman announces a $500 million fund to help the earliest stage sta" New post on Leaders in Pharmaceutical Business Intelligence (LPBI) Group Greylock Partners Announces Unique $500 Million Venture to act as Seed Capital Funding for Earliest Stage Startups by sjwilliamspa Greylock Partners Announces Unique $500 Million Venture to act as Seed Capital Funding for Earliest Stage Startups Reporter: Stephen J. Williams, Ph.D. Greylock Partners CEO Reid Hoffman announces a $500 million fund to help the earliest stage startups find capital. See video below: https://www.bloomberg.com/multimedia/api/embed/iframe?id=798828e9-7850-4c83-9348-a35d5fad3e1c https://www.bloomberg.com/news/videos/2021-09-24/intv-sara-guoh-greylock-partners-video See transcript from Bloomberg.com 00:00This is a lot of money […] Read more of this post sjwilliamspa | October 16, 2021 at 12:52 pm | Tags: Biotech Investment and Venture Growth: The Franchising of Intellectual Property as a Business Model, biotech startup, Global Partnering & Biotech Investment, Greylock Partners, Reid Hoffman, seed capital, seed funding, startup funding, tech startup, Venture capital | Categories: BioTechnology - Venture Creation, BioTechnology - Venture Creation, Venture Capital, Pharmacodynamics and Pharmacokinetics, Technology Advance Assessment of, Technology Transfer: Biotech and Pharmaceutical, Trends in Global Economy, US and Global Economy: Trends and Findings, Venture Capital | URL: https://wp.me/p2kEDv-heY Comment    See all comments Unsubscribe to no longer receive posts from Leaders in Pharmaceutical Business Intelligence (LPBI) Group. Change your email settings at Manage Subscriptions. Trouble clicking? Copy and paste this URL into your browser: https://pharmaceuticalintelligence.com/2021/10/16/greylock-partners-announces-unique-500-million-venture-to-act-as-seed-capital-funding-for-earliest-stage-startups/